ST

Sindhu Tare

Active Director Director DIN 00366547
DIN 00366547 First appointment Apr 2005 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2005
Shareholding value •••• Premium profile

About Sindhu Tare

Data last updated:

Sindhu Tare is a Director at Curewin Pharmaceuticals Private Limited (since 2005). The company operates in Healthcare. Curewin Pharmaceuticals Private Limited reported revenue of ₹2.88 Cr (FY 2024).

DIN 00366547
Primary Designation Director
Industry Healthcare
First Appointment 01 Apr 2005
Oldest Company Age 36 yrs
Largest company Curewin Pharmaceuticals Private Limited · ₹2.88 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20051990₹2.88 Cr (FY 2024)Active

Board colleagues of Sindhu Tare

Directorship timeline

Open interactive timeline →
Curewin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sindhu Tare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sindhu Tare

Sindhu Tare currently holds 1 directorship: Curewin Pharmaceuticals Private Limited (Director, since 01 Apr 2005, revenue ₹2.88 Cr (FY 2024)).

Sindhu Tare was first appointed on 01 Apr 2005 as Director at Curewin Pharmaceuticals Private Limited.

The current boards of Sindhu Tare's companies include Rajendra Tare (Curewin Pharmaceuticals Private Limited), Virendra Tare (Curewin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available